TRUE™ Tissue Technology

Our proprietary TRUE™ Tissue technology platform is currently available for investigational use only.

TRUE™ Tissue developed from cells isolated from donor tissue and is 100% biological. There are no synthetic materials or chemical fixation used, and implanted tissues are completely cell-derived and acellular.

That’s how we make tissues that are TRUE to Nature™.

Preclinical in vivo and in vitro testing has demonstrated that TRUE™ Tissue is:

  • Non-calcific
  • Non-immunogenic
  • Regenerative
  • Mechanically comparable to native tissue
  • Ready to use, off-the-shelf allograft
Discover the difference TRUE™ Tissue makes as an implantable biomaterial platform. TRUE™ Tissue can be readily manufactured for a range of medical devices, implantation sites and geometries. It’s time to replace synthetic biomaterials with TRUE™ Tissue technology and enjoy the benefits of staying TRUE to Nature™.

Contact us to discuss how you can implement TRUE™ Tissue technology in the development of your medical device.

TRUE™ Vascular Graft
TRUE™ Heart Valve
TRUE™ Patch

TRUE™ Tissue Technology Pipeline


Vascudyne Image

Vascudyne Receives BioBusiness Award from Regenerative Medicine Minnesota for Treatment of Nerve Injury

VASA Conference Image

Vascudyne Announces Presentation of First Clinical Results of TRUE AVC™ in Hemodialysis Access at the VASA Conference

Vascudyne Lab

Regenerative Medicine Company Vascudyne Relocates to High Capacity GMP Manufacturing Facility

Autm better world project image

Vascudyne’s TRUE Tissue Technology is a Top 3 2022 Better World Project Award Finalist

Regenerative Medicine Vascular Graft for Hemodialysis Access

Regenerative Medicine Company Vascudyne Closes $10 Million Series A Financing

Vascudyne announces successful First Human Use of TRUE™ Vascular Graft for hemodialysis access

Vascudyne’s CSO presents at the Heart Valve Society Meeting on tissue remodeling of engineered valved conduit evaluated at 52 weeks in the growing lamb

Lab-created heart valves can grow with the recipient article published in Science Translational Medicine

Proud Member of:

11 + 15 =

Copyright 2021 | Vascudyne, Inc.